Revenio Group Oyj Logo

Revenio Group Oyj

ISIN: FI0009010912 | Ticker: REG1V | LEI: 743700I27E0FWSXLKK04
Sector: Health CareSub-Industry: Health Care Technology
Country: Finland

About Revenio Group Oyj

Company Description

Revenio is a global leader in ophthalmic diagnostics and ophthalmic devices. Revenio Group's ophthalmic diagnostic solutions include intraocular pressure measurement devices under the iCare brand, retinal imaging devices and perimeters. The main tools for the detection and diagnosis of glaucoma and its monitoring during treatment are intraocular pressure measurement (tonometry), retinal imaging, and visual field tests (perimetry).

The Revenio Group comprises Revenio Group Corporation, Icare Finland Oy, Icare USA Inc., Revenio Italy S. R. L, CenterVue SpA, Revenio Research Oy, Revenio Australia Pty Ltd, Icare World Australia Pty Ltd, CT Operations International UK Ltd, Done Medical Oy and Oscare Medical Oy.

Revenio Group Corporation is listed on Nasdaq Helsinki with the trading code REG1V.

Served area

Worldwide

Headquarters

Äyritie 22, 1510 Vantaa – Finland

Financial statements

Download as Excel
Line item in (eur) 02.01.2019 01.01.2020 02.01.2020 01.01.2021 02.01.2021 01.01.2022 02.01.2022 01.01.2023
Assets N/A 109,791,000.00 N/A 114,419,000.00 N/A 124,583,000.00 N/A 136,091,000.00
Noncurrent Assets N/A 72,496,000.00 N/A 70,378,000.00 N/A 83,731,000.00 N/A 83,592,000.00
Property Plant And Equipment N/A 1,809,000.00 N/A 2,018,000.00 N/A 2,554,000.00 N/A 2,848,000.00
Goodwill N/A 50,409,000.00 N/A 50,409,000.00 N/A 59,815,000.00 N/A 59,768,000.00
Intangible Assets Other Than Goodwill N/A 19,438,000.00 N/A 16,861,000.00 N/A 17,969,000.00 N/A 17,083,000.00
Deferred Tax Assets N/A N/A N/A N/A N/A 1,308,000.00 N/A 1,589,000.00
Other Noncurrent Financial Assets N/A N/A N/A N/A N/A 200,000.00 N/A 417,000.00
Current Assets N/A 37,295,000.00 N/A 44,041,000.00 N/A 40,852,000.00 N/A 52,500,000.00
Current Tax Assets Current N/A N/A N/A 714,000.00 N/A 139,000.00 N/A 806,000.00
Cash and cash equivalents 10,378,000.00 26,675,000.00 26,675,000.00 28,878,000.00 28,878,000.00 25,216,000.00 25,216,000.00 32,062,000.00
Equity And Liabilities N/A 109,791,000.00 N/A 114,419,000.00 N/A 124,583,000.00 N/A 136,091,000.00
Equity 18,042,000.00 64,363,000.00 64,363,000.00 69,710,000.00 N/A 78,429,000.00 N/A 90,916,000.00
Issued Capital N/A 5,315,000.00 N/A 5,315,000.00 N/A 5,315,000.00 N/A 5,315,000.00
Retained Earnings N/A 7,999,000.00 N/A 13,971,000.00 N/A 22,125,000.00 N/A 34,290,000.00
Treasury Shares N/A 740,000.00 N/A 2,333,000.00 N/A 2,149,000.00 N/A 1,907,000.00
Other Reserves N/A 280,000.00 N/A 280,000.00 N/A 280,000.00 N/A 280,000.00
Reserve Of Sharebased Payments N/A 300,000.00 N/A 300,000.00 N/A 300,000.00 N/A N/A
Liabilities N/A 45,428,000.00 N/A 44,709,000.00 N/A 46,154,000.00 N/A 45,175,000.00
Noncurrent Liabilities N/A 29,888,000.00 N/A 26,591,000.00 N/A 5,588,000.00 N/A 19,511,000.00
Noncurrent Provisions For Employee Benefits N/A 428,000.00 N/A 701,000.00 N/A 777,000.00 N/A 740,000.00
Deferred Tax Liabilities N/A 4,120,000.00 N/A 3,856,000.00 N/A 3,909,000.00 N/A 3,656,000.00
Other Noncurrent Liabilities N/A 1,155,000.00 N/A 0.00 N/A N/A N/A N/A
Longterm Borrowings N/A 23,817,000.00 N/A 21,659,000.00 N/A 0.00 N/A 14,250,000.00
Current Liabilities N/A 15,540,000.00 N/A 18,118,000.00 N/A 40,566,000.00 N/A 25,664,000.00
Current Provisions N/A 397,000.00 N/A 330,000.00 N/A 476,000.00 N/A 485,000.00
Current Tax Liabilities Current N/A 0.00 N/A -714,000.00 N/A N/A N/A N/A
Current Borrowings And Current Portion Of Noncurrent Borrowings N/A 4,259,000.00 N/A 4,604,000.00 N/A 22,709,000.00 N/A 4,200,000.00
Line item in (eur) 01.01.2019/
01.01.2020
01.01.2020/
01.01.2021
01.01.2021/
01.01.2022
01.01.2022/
01.01.2023
Revenue From Contracts With Customers 49,474,000.00 61,067,000.00 78,778,000.00 96,976,000.00
Other Income 1,311,000.00 1,316,000.00 850,000.00 307,000.00
Changes In Inventories Of Finished Goods And Work In Progress 5,396,000.00 -759,000.00 -1,537,000.00 -181,000.00
Raw Materials And Consumables Used 5,899,000.00 14,095,000.00 18,879,000.00 21,581,000.00
Services Expense 3,642,000.00 4,392,000.00 5,681,000.00 5,806,000.00
Employee Benefits Expense 9,772,000.00 12,718,000.00 16,425,000.00 19,351,000.00
Wages And Salaries 8,325,000.00 11,023,000.00 14,369,000.00 16,654,000.00
Social Security Contributions 291,000.00 250,000.00 1,020,000.00 1,251,000.00
Depreciation Amortisation And Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss 2,023,000.00 4,563,000.00 3,620,000.00 3,434,000.00
Depreciation And Amortisation Expense 2,023,000.00 2,606,000.00 2,992,000.00 3,434,000.00
Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss 0.00 1,956,000.00 628,000.00 0.00
Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss 0.00 1,956,000.00 628,000.00 0.00
Other Expense By Nature 11,460,000.00 10,244,000.00 14,457,000.00 17,609,000.00
Profit Loss From Operating Activities 12,593,000.00 17,130,000.00 22,103,000.00 29,683,000.00
Finance Income 5,000.00 1,000.00 248,000.00 53,000.00
Finance Costs 325,000.00 412,000.00 252,000.00 680,000.00
Profit Loss Before Tax 12,273,000.00 16,719,000.00 22,099,000.00 29,056,000.00
Income Tax Expense Continuing Operations 2,930,000.00 3,357,000.00 4,778,000.00 7,303,000.00
Profit (loss) 9,343,000.00 13,362,000.00 17,321,000.00 21,753,000.00
Line item in (eur) 01.01.2020 02.01.2019 01.01.2021 02.01.2020 01.01.2022 02.01.2021 01.01.2023 02.01.2022
Profit (loss) 9,343,000.00 N/A 13,362,000.00 N/A 17,321,000.00 N/A 21,753,000.00 N/A
Adjustments For Income Tax Expense 3,112,000.00 N/A 3,357,000.00 N/A 4,778,000.00 N/A 7,303,000.00 N/A
Adjustments For Decrease Increase In Inventories 729,000.00 N/A -1,423,000.00 N/A -1,539,000.00 N/A -327,000.00 N/A
Adjustments For Sharebased Payments N/A N/A 0.00 N/A -1,077,000.00 N/A -950,000.00 N/A
Other Adjustments For Noncash Items 1,775,000.00 N/A 539,000.00 N/A 569,000.00 N/A 529,000.00 N/A
Interest Paid Classified As Operating Activities -291,000.00 N/A 265,000.00 N/A 247,000.00 N/A 344,000.00 N/A
Interest Received Classified As Operating Activities 5,000.00 N/A 1,000.00 N/A 1,000.00 N/A 53,000.00 N/A
Income Taxes Paid Refund Classified As Operating Activities -3,663,000.00 N/A 3,436,000.00 N/A 4,513,000.00 N/A 6,014,000.00 N/A
Cash Flows From Used In Operating Activities 12,489,000.00 N/A 15,230,000.00 N/A 21,509,000.00 N/A 23,241,000.00 N/A
Cash Flows Used In Obtaining Control Of Subsidiaries Or Other Businesses Classified As Investing Activities 58,227,000.00 N/A 0.00 N/A 11,322,000.00 N/A 0.00 N/A
Purchase Of Property Plant And Equipment Classified As Investing Activities 824,000.00 N/A 840,000.00 N/A 1,235,000.00 N/A 1,113,000.00 N/A
Purchase Of Intangible Assets Classified As Investing Activities 661,000.00 N/A 702,000.00 N/A 780,000.00 N/A 883,000.00 N/A
Cash Advances And Loans Made To Other Parties Classified As Investing Activities 0.00 N/A 50,000.00 N/A 200,000.00 N/A 160,000.00 N/A
Cash Flows From Used In Investing Activities -59,713,000.00 N/A -1,591,000.00 N/A -13,538,000.00 N/A -2,155,000.00 N/A
Proceeds From Issuing Shares 42,300,000.00 N/A 0.00 N/A N/A N/A N/A N/A
Payments To Acquire Or Redeem Entitys Shares 0.00 N/A 1,613,000.00 N/A 0.00 N/A N/A N/A
Repayments Of Borrowings Classified As Financing Activities 2,248,000.00 N/A 2,159,000.00 N/A 3,209,000.00 N/A 4,259,000.00 N/A
Payments Of Lease Liabilities Classified As Financing Activities 580,000.00 N/A 659,000.00 N/A 708,000.00 N/A 846,000.00 N/A
Dividends Paid Classified As Financing Activities 6,709,000.00 N/A 7,948,000.00 N/A 8,498,000.00 N/A 9,036,000.00 N/A
Cash Flows From Used In Financing Activities 63,549,000.00 N/A -11,075,000.00 N/A -12,140,000.00 N/A -14,141,000.00 N/A
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes 16,326,000.00 N/A 2,564,000.00 N/A -4,169,000.00 N/A 6,944,000.00 N/A
Effect Of Exchange Rate Changes On Cash And Cash Equivalents 54.00 N/A -360,000.00 N/A 507,000.00 N/A -99,000.00 N/A
Cash and cash equivalents 26,675,000.00 10,378,000.00 28,878,000.00 26,675,000.00 25,216,000.00 28,878,000.00 32,062,000.00 25,216,000.00

Please note that some sums might not add up.

Filings & Publications

2022

Report
Q1
H1
Q3
FY
Consolidated Report
FIN / ENG
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

2021

Report
Q1
H1
Q3
FY
Consolidated Report
FIN / ENG
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

2020

Report
Q1
H1
Q3
FY
Consolidated Report
ENG / FIN
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

Insider Trades

Sign up and we will give you access!

Capital markets information

ISIN

FI0009010912

LEI

743700I27E0FWSXLKK04

Sector

Health Care

Industry Group

Health Care Equipment & Services

Industry

Health Care Technology

Sub-Industry

Health Care Technology

Listed Stock Exchange

Nasdaq Helsinki

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.